Pembrolizumab in Metastatic Anal Cancer
Clinical trial NCT02919969 · COMPLETED
Trial details
- NCT number
- NCT02919969
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-11
- Primary completion
- 2021-12-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.